Janux Therapeutics (JANX) Operating Expenses (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly Operating Expenses of $37.9 million for Q1 2026, up 8.74% year-over-year from $34.9 million in Q1 2025, and down 10.51% quarter-over-quarter from $42.4 million in Q4 2025.
Janux Therapeutics (JANX) Operating Expenses (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Operating Expenses for 7 consecutive years, with $37.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 8.74% year-over-year to $37.9 million; the TTM figure through Mar 2026 stood at $170.7 million (up 38.88% YoY), while the FY2025 annual figure was $167.7 million, up 53.21% from the prior year.
- Operating Expenses declined to $37.9 million in Q1 2026 per JANX's latest filing, from $42.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $45.3 million in Q3 2025 and bottomed at $15.1 million in Q1 2022.
- Historically, Operating Expenses has averaged $27.8 million across 5 years, with a median of $22.3 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 467.98% — and 2023, when it fell 11.9%.
- Janux Therapeutics' Operating Expenses stood at $21.1 million in 2022, then fell by 11.9% to $18.6 million in 2023, then jumped by 56.05% to $29.0 million in 2024, then soared by 46.1% to $42.4 million in 2025, then declined by 10.51% to $37.9 million in 2026.
- Business Quant data shows JANX's Operating Expenses at $37.9 million in Q1 2026, $42.4 million in Q4 2025, and $45.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | 41.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.96 Mn |
| Mar 31, 2026 | 37.95 Mn |
| Dec 31, 2025 | 42.40 Mn |
| Sep 30, 2025 | 45.25 Mn |
| Jun 30, 2025 | 45.12 Mn |
| Mar 31, 2025 | 34.90 Mn |
| Dec 31, 2024 | 29.02 Mn |
| Sep 30, 2024 | 36.28 Mn |
| Jun 30, 2024 | 22.72 Mn |
| Mar 31, 2024 | 21.41 Mn |
| Dec 31, 2023 | 18.60 Mn |
| Sep 30, 2023 | 18.33 Mn |
| Jun 30, 2023 | 21.81 Mn |
| Mar 31, 2023 | 22.33 Mn |
| Dec 31, 2022 | 21.11 Mn |
| Sep 30, 2022 | 19.84 Mn |
| Jun 30, 2022 | 19.63 Mn |
| Mar 31, 2022 | 15.13 Mn |
| Dec 31, 2021 | 15.11 Mn |
| Sep 30, 2021 | 12.06 Mn |